Korea Investment CORP boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 47.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 601,571 shares of the medical research company’s stock after purchasing an additional 193,111 shares during the quarter. Korea Investment CORP […]
Continuum Advisory LLC decreased its holdings in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 2.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,123 shares of the medical research company’s stock after selling 164 shares during the quarter. Continuum Advisory LLC’s […]
Argent Trust Co lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 5.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,331 shares of the medical research company’s stock after selling 204 shares during the quarter. Argent Trust […]
Lowell Blake & Associates Inc. grew its stake in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 21.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 131,546 shares of the medical research company’s stock after acquiring an additional 22,979 shares during the period. Edwards Lifesciences accounts for about 3.3% of Lowell Blake & […]
Edwards Lifesciences Co. (NYSE:EW – Get Rating) shares were down 3.7% on Tuesday . The stock traded as low as $85.84 and last traded at $85.84. Approximately 637,271 shares traded hands during trading, a decline of 80% from the average daily volume of 3,170,556 shares. The stock had previously closed at $89.16. Analyst Upgrades and […]